Dale Thomas III, Ph.D. (Co-Founder): he spanned both Mechanical Engineering and Chemical Engineering at MIT. He also completed his MEngM at MIT and BS at Maine Maritime Academy. In his research, he developed an array of flow chemistry platforms for the advanced synthesis of pharmaceuticals and advanced materials. At Mytide Therapeutics, Dale is leading a cross-disciplinary team of scientists, and engineers to overcome decades-long bottlenecks in peptide manufacturing. Peptides promise to increase the rate of drug discovery and access to revolutionary biological treatment with the goal of impacting patients lives.